Amalgamated Bank Trims Position in Progyny, Inc. (NASDAQ:PGNY)

Amalgamated Bank trimmed its stake in Progyny, Inc. (NASDAQ:PGNY) by 41.8% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 23,340 shares of the company’s stock after selling 16,786 shares during the period. Amalgamated Bank’s holdings in Progyny were worth $391,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. RiverPark Advisors LLC raised its holdings in shares of Progyny by 9.6% in the second quarter. RiverPark Advisors LLC now owns 5,408 shares of the company’s stock valued at $155,000 after acquiring an additional 474 shares in the last quarter. Arizona State Retirement System raised its holdings in shares of Progyny by 2.6% in the 2nd quarter. Arizona State Retirement System now owns 24,313 shares of the company’s stock valued at $696,000 after purchasing an additional 609 shares in the last quarter. State of New Jersey Common Pension Fund D lifted its position in shares of Progyny by 1.1% in the 2nd quarter. State of New Jersey Common Pension Fund D now owns 70,717 shares of the company’s stock worth $2,023,000 after purchasing an additional 787 shares during the period. ProShare Advisors LLC lifted its position in shares of Progyny by 4.6% in the 1st quarter. ProShare Advisors LLC now owns 18,346 shares of the company’s stock worth $700,000 after purchasing an additional 804 shares during the period. Finally, Quarry LP boosted its stake in shares of Progyny by 1,900.0% during the second quarter. Quarry LP now owns 880 shares of the company’s stock valued at $25,000 after purchasing an additional 836 shares in the last quarter. 94.93% of the stock is currently owned by institutional investors.

Progyny Trading Down 1.5 %

NASDAQ:PGNY opened at $13.77 on Monday. The firm has a fifty day simple moving average of $17.30 and a 200-day simple moving average of $23.24. Progyny, Inc. has a 12 month low of $13.39 and a 12 month high of $42.08. The company has a market capitalization of $1.17 billion, a P/E ratio of 23.74, a PEG ratio of 1.44 and a beta of 1.44.

Progyny (NASDAQ:PGNY) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The firm had revenue of $286.63 million for the quarter, compared to analysts’ expectations of $296.85 million. During the same quarter in the previous year, the firm posted $0.16 EPS. The firm’s revenue for the quarter was up 2.0% compared to the same quarter last year. Equities analysts forecast that Progyny, Inc. will post 0.64 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on PGNY. BTIG Research lowered Progyny from a “buy” rating to a “neutral” rating in a report on Wednesday, August 7th. Canaccord Genuity Group dropped their price objective on Progyny from $18.00 to $17.00 and set a “hold” rating on the stock in a research report on Wednesday, November 13th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $25.00 target price on shares of Progyny in a report on Tuesday, October 1st. JMP Securities cut shares of Progyny from an “outperform” rating to a “market perform” rating in a report on Thursday, September 19th. Finally, Leerink Partnrs downgraded shares of Progyny from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 7th. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $25.42.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.